Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034915.xml
Download PDF
Onkologische Welt 2018; 09(01): 21-22
DOI: 10.1055/s-0038-1637773
DOI: 10.1055/s-0038-1637773
DGU/Dresden
Neuerungen in Diagnostik, Therapie und Nachsorge
Urologische Tumoren – Update von der DGU-JahrestagungFurther Information
Publication History
Publication Date:
27 February 2018 (online)
Unter dem Motto “Urologie. Für alle. Für jeden. Für uns.” tagten Deutschlands Urologen in Dresden. An der weltweit drittgrößten urologischen Fachtagung nahmen rund 6500 internationale Teilnehmer teil. Kongresspräsident Prof. Tilman Kälble, Fulda, verwies auf die Neuerungen in Diagnostik und Therapie aller urologischen Tumoren als einen Schwerpunkt des Kongresses. Der Stellenwert der Nachsorge bei urologischen Therapien wurde in einer eigens für dieses Thema reservierten Sitzung deutlich.
MissingLinkText
MissingLinkText
-
Literatur
- 1 Crook A. et al. Serum prostate-specific antigen profile following radiotherapy for prostate cancer: Implications for patterns of failure and definition of cure. Urology 1998; 51: 566-572.
- 2 Pound CR. et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-1597.
- 3 Roach M. et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965-974.
- 4 Critz FA. et al. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. J Urol 2000; 163: 1085-1089.
- 5 Ward JF. et al. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 2003; 170: 1872-1876.
-
Literatur
- 1 Crook A. et al. Serum prostate-specific antigen profile following radiotherapy for prostate cancer: Implications for patterns of failure and definition of cure. Urology 1998; 51: 566-572.
- 2 Pound CR. et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-1597.
- 3 Roach M. et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965-974.
- 4 Critz FA. et al. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. J Urol 2000; 163: 1085-1089.
- 5 Ward JF. et al. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 2003; 170: 1872-1876.